A pigment-rich berry best supported for easing screen-related eye strain and modestly improving blood sugar in people who already have diabetes; effects on cholesterol and circulation are less consistent. Brain, skin, cancer, and longevity uses stay unproven. The fruit is very safe — counterfeit products and toxic leaf preparations are the real hazards. (Full Review)

Protocol

Dose

80–160 mg/day

Standardized fruit extract; eye-focused trials used 240 mg/day

Form

Standardized fruit extract

~36% anthocyanins (Mirtoselect reference); fruit, not leaf

Timing

With meals, 1–2×/day

Splitting doses suits the short ~2-hour half-life

Time to effect

Eye strain

4–12 weeks

Improved focusing and reduced eye fatigue

Blood sugar

~12 weeks

Average blood-sugar marker reflects ~3 months

Cholesterol

~4 weeks

Short-term trials showed changes by about four weeks

Benefits

Medium: Relief of digital eye strain and accommodative fatigue; glycemic control in type 2 diabetes; lipid profile improvement

Low: Diabetic retinopathy and retinal microvascular support; endothelial function and blood pressure; chronic venous insufficiency; night vision in healthy individuals; anti-inflammatory and antioxidant biomarker modulation

Speculative: Cognitive function and neuroprotection; colorectal cancer chemoprevention; skin aging; healthspan and longevity pathways

Contraindications

Bleeding disorders

Within ~2 weeks of scheduled surgery

Pregnancy or breastfeeding

Bilberry leaf preparations

Key Interactions

Anticoagulants and antiplatelets (warfarin, clopidogrel, apixaban)

Glucose-lowering drugs (insulin, sulfonylureas, metformin)

Aspirin and NSAIDs (ibuprofen, naproxen)

Blood-thinning supplements (fish oil, ginkgo, garlic, high-dose vitamin E, curcumin)

Blood-sugar-lowering supplements (berberine, cinnamon, alpha-lipoic acid, chromium)

Risk & Side Effects

Medium: Bilberry leaf toxicity with chronic high-dose use

Low: Mild gastrointestinal discomfort; additive blood-sugar lowering; increased bleeding tendency

Speculative: Allergic reactions; unknown long-term effects of high-dose extracts

Monitoring

Marker	Target	Why
HbA1c	< 5.4%	Average blood sugar; primary metabolic target
Fasting glucose	75–90 mg/dL	Detects short-term blood-sugar change
Fasting insulin / HOMA-IR	Insulin < 6 µIU/mL; HOMA-IR < 1.5	Estimates insulin resistance
LDL cholesterol	< 100 mg/dL	Main lipid target given conflicting effects
Triglycerides	< 80 mg/dL	Blood fat that may respond
hs-CRP	< 1.0 mg/L	General inflammation marker
Blood pressure	< 120/80 mmHg	Tracks any modest vascular effect
INR (if on warfarin)	Often 2.0–3.0	Detects additive bleeding risk with anticoagulants

Cadence: Recheck relevant labs ~12 weeks after starting, then every 6–12 months; glucose self-monitoring after starting and INR within 1–2 weeks for warfarin users

Qualitative Assessment

Visual comfort: less eye strain, dryness, or fatigue during prolonged screen or near work
Energy and general well-being: subjective steadiness through the day
Cognitive clarity: any perceived improvement in focus or mental sharpness
Circulatory symptoms: reduced leg heaviness or swelling

Bilberry for Health & Longevity

Protocol

Benefits

Risk & Side Effects

Monitoring

Qualitative Assessment